One Breast Cancer Test – Three Critical Answers
1. Can I safely forego chemotherapy?
2. How significant will my benefit from chemotherapy be?
3. Will I still need hormonal therapy after 5 years?
Why EndoPredict Breast Cancer Test?
Myriad Genetics is a leading molecular diagnostic company based in USA. Available in India since 2015, EndoPredict has helped hundreds of Indian women decide their breast cancer treatment plan.
Positive Bioscience is the exclusive partner for Myriad Genetics and only authorised provider of EndoPredict in India.
Our brochure explains in detail the benefits of the test as well as what is included.
ASCO Breast Cancer Guidelines recommend Endopredict Breast Cancer Testing
EndoPredict is superior than its competitors in multiple aspects
An easy to use report for making adjuvant chemotherapy decisions for breast cancer care. Improve your quality of life and make smart treatment decisions with EndoPredict test.
Make treatment decisions that’s right for you
For patients who have a long-term risk of recurrence that is low, adding chemotherapy is unlikely to improve the absolute benefit.
For patients who have a long-term risk of recurrence that is high, adding chemotherapy may significantly lower the risk.
Testimonials
Order EndoPredict Now
Myriad’s EndoPredict Breast Cancer Test will help your doctor and you decide if you can safely avoid chemotherapy and how beneficial chemotherapy will be.
Contents
show